Literature DB >> 10899927

Protective effect of harmalol and harmaline on MPTP neurotoxicity in the mouse and dopamine-induced damage of brain mitochondria and PC12 cells.

C S Lee1, E S Han, Y Y Jang, J H Han, H W Ha, D E Kim.   

Abstract

The present study elucidated the protective effect of beta-carbolines (harmaline, harmalol, and harmine) on oxidative neuronal damage. MPTP treatment increased activities of total superoxide dismutase, catalase, and glutathione peroxidase and levels of malondialdehyde and carbonyls in the basal ganglia, diencephalon plus midbrain of brain compared with control mouse brain. Coadministration of harmalol (48 mg/kg) attenuated the MPTP effect on the enzyme activities and formation of tissue peroxidation products. Harmaline, harmalol, and harmine attenuated both the 500 microM MPP(+)-induced inhibition of electron flow and membrane potential formation and the 100 microM dopamine-induced thiol oxidation and carbonyl formation in mitochondria. The scavenging action of beta-carbolines on hydroxyl radicals was represented by inhibition of 2-deoxy-D-ribose degradation. Harmaline and harmalol (100 microM) attenuated 200 microM dopamine-induced viability loss in PC12 cells. The beta-carbolines (50 microM) attenuated 50 microM dopamine-induced apoptosis in PC12 cells. The compounds alone did not exhibit significant cytotoxic effects. The results indicate that beta-carbolines attenuate brain damage in mice treated with MPTP and MPP(+)-induced mitochondrial damage. The compounds may prevent dopamine-induced mitochondrial damage and PC12 cell death through a scavenging action on reactive oxygen species and inhibition of monoamine oxidase and thiol oxidation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899927     DOI: 10.1046/j.1471-4159.2000.0750521.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years.

Authors:  Rafael G Dos Santos; Flávia L Osório; José Alexandre S Crippa; Jordi Riba; Antônio W Zuardi; Jaime E C Hallak
Journal:  Ther Adv Psychopharmacol       Date:  2016-03-18

2.  Effect of R-(-)-deprenyl and harmaline on dopamine- and peroxynitrite-induced membrane permeability transition in brain mitochondria.

Authors:  Chung Soo Lee; Chung Seok Lee; Hyun Hee Ko; Jin Ho Song; Eun Sook Han
Journal:  Neurochem Res       Date:  2002-03       Impact factor: 3.996

3.  Protective effect of 1-methylated beta-carbolines against 3-morpholinosydnonimine-induced mitochondrial damage and cell viability loss in PC12 cells.

Authors:  Won Tae Choi; Young Chul Youn; Eun Sook Han; Chung Soo Lee
Journal:  Neurochem Res       Date:  2004-10       Impact factor: 3.996

4.  Modulation of voltage-gated channel currents by harmaline and harmane.

Authors:  Frank Splettstoesser; Udo Bonnet; Martin Wiemann; Dieter Bingmann; Dietrich Büsselberg
Journal:  Br J Pharmacol       Date:  2005-01       Impact factor: 8.739

5.  Effects of CYP2D6 status on harmaline metabolism, pharmacokinetics and pharmacodynamics, and a pharmacogenetics-based pharmacokinetic model.

Authors:  Chao Wu; Xi-Ling Jiang; Hong-Wu Shen; Ai-Ming Yu
Journal:  Biochem Pharmacol       Date:  2009-05-13       Impact factor: 5.858

6.  (2S)-5, 2', 5'-trihydroxy-7-methoxyflavanone, a natural product from Abacopteris penangiana, presents neuroprotective effects in vitro and in vivo.

Authors:  Han Wei; Guanghua Wu; Jinglou Chen; Xuenong Zhang; Chaomei Xiong; Yongfang Lei; Wei Chen; Jinlan Ruan
Journal:  Neurochem Res       Date:  2013-05-14       Impact factor: 3.996

7.  Effects of the organochlorine pesticide methoxychlor on dopamine metabolites and transporters in the mouse brain.

Authors:  Rosemary A Schuh; Jason R Richardson; Rupesh K Gupta; Jodi A Flaws; Gary Fiskum
Journal:  Neurotoxicology       Date:  2009-03       Impact factor: 4.294

8.  Inhibition of SIN-1-induced change in mitochondrial membrane permeability in PC12 cells by dopamine.

Authors:  Chung Soo Lee; Eun Sook Han; Jin Ho Song; Kyung Yong Kim
Journal:  Neurochem Res       Date:  2004-07       Impact factor: 3.996

9.  Protective effect of erythropoietin against 1-methyl-4-phenylpyridinium-induced neurodegenaration in PC12 cells.

Authors:  Yan Wu; You Shang; Sheng-Gang Sun; Ren-Gang Liu; Wen-Qiong Yang
Journal:  Neurosci Bull       Date:  2007-05       Impact factor: 5.203

10.  Antioxidant effect of phenelzine on MPP+-induced cell viability loss in differentiated PC12 cells.

Authors:  Chung Soo Lee; Eun Sook Han; Won Bok Lee
Journal:  Neurochem Res       Date:  2003-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.